Ethallobarbital
Ethallobarbital is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which make it useful in the treatment of insomnia and other sleep disorders.
Chemical Structure and Properties[edit | edit source]
Ethallobarbital belongs to the class of barbiturates, which are derivatives of barbituric acid. The chemical structure of ethallobarbital includes a pyrimidine ring fused with a urea moiety, and it is characterized by the presence of an ethyl group at the 5-position of the barbituric acid core.
Pharmacology[edit | edit source]
Ethallobarbital acts on the central nervous system (CNS) by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter. This action results in increased GABA-ergic inhibition, leading to sedative and hypnotic effects. The drug is metabolized in the liver and excreted through the kidneys.
Medical Uses[edit | edit source]
Ethallobarbital has been used primarily for its sedative and hypnotic effects. It is prescribed for the short-term treatment of insomnia and for inducing anesthesia in medical procedures. Due to the risk of dependence and the development of safer alternatives, its use has declined over the years.
Side Effects and Risks[edit | edit source]
Common side effects of ethallobarbital include drowsiness, dizziness, and headache. Prolonged use can lead to tolerance, dependence, and withdrawal symptoms. Overdose can result in severe respiratory depression, coma, and even death.
History[edit | edit source]
Ethallobarbital was first synthesized in the early 20th century as part of the development of barbiturate drugs. It was one of many barbiturates used for their sedative and hypnotic properties before the advent of benzodiazepines and other modern sedatives.
Regulation[edit | edit source]
Due to its potential for abuse and dependence, ethallobarbital is classified as a controlled substance in many countries. Its use is strictly regulated, and it is available only by prescription.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
